#
# List of summaries for testing.  Each line is the following format:
#
# Gene\tVariant\tTumorType\tSummaries
#
# where AUTHORITIES is a semicolon separated list of authorities
#
# Current valid authorities: ROLE_USER, ROLE_MANAGER
#
ABL1	BCR-ABL1 Fusion	Acute Lymphoid Leukemia	Imatinib is FDA-approved for the treatment of patients with BCR-ABL1 fusion positive acute lymphoid or chronic myelogenous leukemias.
